Evidence map›Paper›PMID 31701871›Full record

ArticleeLife2019

Wedging open a catalytic site.

Annie Beuve

Abstract readComment
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  3. Article
  4. GAPDH delivers heme to soluble guanylyl cyclase.The Journal of biological chemistry · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Annie BeuveDepartment of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Rutgers, the State University of New Jersey, Newark, United States.ORCID 0000-0003-4389-5388

Funding

Regulation of Soluble Guanylyl Cyclase, the NO-ReceptorR01GM067640 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI BEUVE, ANNIE V · 2003 to 2021
$5.8M
NIGMS NIH HHS R01 GM067640
6 · The paper itself

Abstract

The activation mechanism of the nitric oxide receptor has been revealed by cryo-electron microscopy.

Indexed as

Cyclic GMPManducaAnimalsCatalytic DomainCryoelectron MicroscopyNitric OxideSoluble Guanylyl CyclaseCyclic GMPNitric OxideSoluble Guanylyl Cyclaseallosterybiochemistrychemical biologyCryoEMcyclic GMPmanduca sextanitric oxidenone

Identifiers

PMID31701871
PMCPMC6839915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.